Literature DB >> 33658374

Discordant clinical features of identical hypertrophic cardiomyopathy twins.

Giuliana G Repetti1, Yuri Kim1,2, Alexandre C Pereira3, Jodie Ingles4,5, Mark W Russell6, Neal K Lakdawala2, Carolyn Y Ho2, Sharlene Day7, Christopher Semsarian4,5, Barbara McDonough1,8, Steven R DePalma1,8, Daniel Quiat1,9, Eric M Green10, Christine E Seidman1,2,8, J G Seidman11.   

Abstract

Hypertrophic cardiomyopathy (HCM) is a disease of heart muscle, which affects ∼1 in 500 individuals and is characterized by increased left ventricular wall thickness. While HCM is caused by pathogenic variants in any one of eight sarcomere protein genes, clinical expression varies considerably, even among patients with the same pathogenic variant. To determine whether background genetic variation or environmental factors drive these differences, we studied disease progression in 11 pairs of monozygotic HCM twins. The twin pairs were followed for 5 to 14 y, and left ventricular wall thickness, left atrial diameter, and left ventricular ejection fraction were collected from echocardiograms at various time points. All nine twin pairs with sarcomere protein gene variants and two with unknown disease etiologies had discordant morphologic features of the heart, demonstrating the influence of nonhereditable factors on clinical expression of HCM. Whole genome sequencing analysis of the six monozygotic twins with discordant HCM phenotypes did not reveal notable somatic genetic variants that might explain their clinical differences. Discordant cardiac morphology of identical twins highlights a significant role for epigenetics and environment in HCM disease progression.

Entities:  

Keywords:  genetics; hypertrophic cardiomyopathy; identical twins

Mesh:

Substances:

Year:  2021        PMID: 33658374      PMCID: PMC7958207          DOI: 10.1073/pnas.2021717118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  43 in total

1.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  J Thorac Cardiovasc Surg       Date:  2011-12       Impact factor: 5.209

2.  Different Clinical Presentation and Tissue Characterization in a Monozygotic Twin Pair with MYH7 Mutation-Related Hypertrophic Cardiomyopathy.

Authors:  Jie Wang; Weihao Li; Yuchi Han; Yucheng Chen
Journal:  Int Heart J       Date:  2019-02-08       Impact factor: 1.862

3.  Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies.

Authors:  Chengliang Dong; Peng Wei; Xueqiu Jian; Richard Gibbs; Eric Boerwinkle; Kai Wang; Xiaoming Liu
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

Review 4.  Reproducibility of echocardiographic left ventricular measurements.

Authors:  D C Wallerson; R B Devereux
Journal:  Hypertension       Date:  1987-02       Impact factor: 10.190

Review 5.  New perspectives on the prevalence of hypertrophic cardiomyopathy.

Authors:  Christopher Semsarian; Jodie Ingles; Martin S Maron; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2015-03-31       Impact factor: 24.094

6.  Impact of Obesity on Left Ventricular Thickness in Children with Hypertrophic Cardiomyopathy.

Authors:  Seshadri Balaji; Michael P DiLorenzo; Frank A Fish; Susan P Etheridge; Peter F Aziz; Mark W Russell; Svjetlana Tisma; Andreas Pflaumer; Narayanswami Sreeram; Peter Kubus; Ian H Law; Michal J Kantoch; Naomi J Kertesz; Margaret Strieper; Christopher C Erickson; Jeremy P Moore; Stephanie J Nakano; Harinder R Singh; Philip Chang; Mitchell Cohen; Anne Fournier; Maria V Ilina; Richard T Smith; Frank Zimmerman; Michaela Horndasch; Walter Li; Anjan Batra; Leonardo Liberman; Robert Hamilton; Christopher M Janson; Shubhayan Sanatani; Ilana Zeltser; George McDaniel; Andrew D Blaufox; Jason M Garnreiter; Hannah Katcoff; Maully Shah
Journal:  Pediatr Cardiol       Date:  2019-07-01       Impact factor: 1.655

7.  Low agreement between cardiologists diagnosing left ventricular hypertrophy in children with end-stage renal disease.

Authors:  Nikki J Schoenmaker; Johanna H van der Lee; Jaap W Groothoff; Gabrielle G van Iperen; Ingrid M E Frohn-Mulder; Ronald B Tanke; Jaap Ottenkamp; Irene M Kuipers
Journal:  BMC Nephrol       Date:  2013-08-02       Impact factor: 2.388

8.  Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy.

Authors:  B J Maron; P Spirito; Y Wesley; J Arce
Journal:  N Engl J Med       Date:  1986-09-04       Impact factor: 91.245

9.  Analysis of protein-coding genetic variation in 60,706 humans.

Authors:  Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur
Journal:  Nature       Date:  2016-08-18       Impact factor: 49.962

10.  Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy.

Authors:  Francesco Mazzarotto; Upasana Tayal; Rachel J Buchan; William Midwinter; Alicja Wilk; Nicola Whiffin; Risha Govind; Erica Mazaika; Antonio de Marvao; Timothy J W Dawes; Leanne E Felkin; Mian Ahmad; Pantazis I Theotokis; Elizabeth Edwards; Alexander Y Ing; Kate L Thomson; Laura L H Chan; David Sim; A John Baksi; Antonis Pantazis; Angharad M Roberts; Hugh Watkins; Birgit Funke; Declan P O'Regan; Iacopo Olivotto; Paul J R Barton; Sanjay K Prasad; Stuart A Cook; James S Ware; Roddy Walsh
Journal:  Circulation       Date:  2020-01-27       Impact factor: 29.690

View more
  3 in total

1.  The Many Faces of Arterial Hypertension in Hypertrophic Cardiomyopathy and Its Phenocopies: Bystander, Consequence, Modifier.

Authors:  Giacomo Tini; Camillo Autore; Beatrice Musumeci
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-04-27

Review 2.  Critical Evaluation of Current Hypotheses for the Pathogenesis of Hypertrophic Cardiomyopathy.

Authors:  Marko Ušaj; Luisa Moretto; Alf Månsson
Journal:  Int J Mol Sci       Date:  2022-02-16       Impact factor: 5.923

3.  Monochorionic twins with 15q26.3 duplication presenting with selective intrauterine growth restriction and discordant cardiac anomalies: A case report.

Authors:  Suraj Kannan; Joann N Bodurtha; Ada Hamosh; Christopher Jordan
Journal:  Mol Genet Genomic Med       Date:  2022-07-06       Impact factor: 2.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.